Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Director George L. Sing proposed to sell 1,000 shares of Common stock with an aggregate market value of $957,687.10 through Morgan Stanley Smith Barney LLC Executive Financial Services. The sale is approximated to take place on November 17, 2026. The shares were originally acquired on April 9, 1991.
Key facts
- Seller
- GEORGE L. SING
- Relationship
- Director
- Shares to sell
- 1,000
- Market value
- $957,687.10
- Approximate sale date
- Nov 17, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Apr 9, 1991 · Private Acquisition from Issuer/Affiliate
More REGN filings
- S-8
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.